Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerber

Showing results (381-390 of 392) with videos related to

Pageof 40
Sort By:
European Journal of Neurology|June 20, 2020
Predicting outcomes after acute reperfusion therapy for basilar artery occlusionA P Jadhav, S M Desai, D M Panczykowski, et al.
The Journal of Biological Chemistry|January 7, 2021
Human genetic variants disrupt RGS14 nuclear shuttling and regulation of LTP in hippocampal neuronsKatherine E Squires, Kyle J Gerber, Matthew C Tillman, et al.
Animal : an International Journal of Animal Bioscience|June 7, 2013
Technical options for the mitigation of direct methane and nitrous oxide emissions from livestock: a reviewP J Gerber, A N Hristov, B Henderson, et al.
Journal of Cardiac Failure|December 20, 2005
Rationale and design of the enoximone clinical trials programBrian D Lowes, Simon F Shakar, Marco Metra, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2013
Working memory impairment in calcineurin knock-out mice is associated with alterations in synaptic vesicle cycling and disruption of high-frequency synaptic and network activity in prefrontal cortexJeffrey R Cottrell, Jonathan M Levenson, Sung Hyun Kim, et al.
American Heart Journal|October 31, 2007
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trialArthur M Feldman, Ron M Oren, William T Abraham, et al.
Molecular Therapy. Nucleic Acids|July 21, 2022
Developing antisense oligonucleotides for a <i>TECPR2</i> mutation-induced, ultra-rare neurological disorder using patient-derived cellular modelsLuis A Williams, David J Gerber, Amy Elder, et al.
Immunity|March 26, 2002
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infectionA Ioan-Facsinay, S J de Kimpe, S M M Hellwig, et al.
Gigascience|April 5, 2016
Brainhack: a collaborative workshop for the open neuroscience communityR Cameron Craddock, Daniel S Margulies, Pierre Bellec, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein TargetsStephen Ph Alexander, Eamonn Kelly, Alistair Mathie, et al.
Pageof 40

Showing results (381-390 of 392) with videos related to

Sort By:
Pageof 40
European Journal of Neurology|June 20, 2020
Predicting outcomes after acute reperfusion therapy for basilar artery occlusionA P Jadhav, S M Desai, D M Panczykowski, et al.
The Journal of Biological Chemistry|January 7, 2021
Human genetic variants disrupt RGS14 nuclear shuttling and regulation of LTP in hippocampal neuronsKatherine E Squires, Kyle J Gerber, Matthew C Tillman, et al.
Animal : an International Journal of Animal Bioscience|June 7, 2013
Technical options for the mitigation of direct methane and nitrous oxide emissions from livestock: a reviewP J Gerber, A N Hristov, B Henderson, et al.
Journal of Cardiac Failure|December 20, 2005
Rationale and design of the enoximone clinical trials programBrian D Lowes, Simon F Shakar, Marco Metra, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 5, 2013
Working memory impairment in calcineurin knock-out mice is associated with alterations in synaptic vesicle cycling and disruption of high-frequency synaptic and network activity in prefrontal cortexJeffrey R Cottrell, Jonathan M Levenson, Sung Hyun Kim, et al.
American Heart Journal|October 31, 2007
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trialArthur M Feldman, Ron M Oren, William T Abraham, et al.
Molecular Therapy. Nucleic Acids|July 21, 2022
Developing antisense oligonucleotides for a <i>TECPR2</i> mutation-induced, ultra-rare neurological disorder using patient-derived cellular modelsLuis A Williams, David J Gerber, Amy Elder, et al.
Immunity|March 26, 2002
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infectionA Ioan-Facsinay, S J de Kimpe, S M M Hellwig, et al.
Gigascience|April 5, 2016
Brainhack: a collaborative workshop for the open neuroscience communityR Cameron Craddock, Daniel S Margulies, Pierre Bellec, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein TargetsStephen Ph Alexander, Eamonn Kelly, Alistair Mathie, et al.
Pageof 40